June 1, 2016
  • Some Alternative Therapy Use Linked to Lower Chemotherapy Initiation

    How does use of dietary supplements and multiple types of complementary and alternative medicine (CAM) affect willingness to initiate chemotherapy in women with early-stage breast cancer, even when the treatment is indicated? That was the issue tackled recently by researchers. Here are the results.

  • Price Increases for Existing Drugs Help Drive Pharmaceutical Spending Rise

    Expensive new drugs and price jumps for older generics accounted for increases in total pharmaceutical expenditures by U.S. hospitals and clinics in 2015, and analysts expect those trends to continue. Find out how much drug costs are expected to increase overall by 2020.

  • Computer Simulation Study Makes Case for Lowering Blood Pressure Goals
    While new guidelines relaxed some blood pressure goals in 2014, a new study argues that might have been a mistake. Instead, the research based on computer simulation found that patients fare better when they are treated more intensively to lower blood pressure readings. Find out how low they think those goals should go.
  • Diabetes Drug Not Effective for Nonalcoholic Fatty Liver Disease

    Previous studies had raised hopes that sitagliptin might be effective treatment for nonalcoholic fatty liver disease, which affects millions of patients in the United States. The first randomized, double-blind, controlled clinical trial found, however, that the oral antihyperglycemic performed no better than a placebo, although it proved to be safe. Here are the details.


Connect With U.S. Pharmacist
USP Google AppUSP Itunes App